UnitedHealth and Goldman Sachs Surge After BofA Upgrade
UnitedHealth shares surged more than 5% on Thursday after Bank of America upgraded the stock to Buy, citing improving medical cost trends. Goldman Sachs also rose nearly 5%, making both stocks the top gainers in the Dow Jones Industrial Average.
Key Numbers
UnitedHealth (UNH) shares jumped more than 5% on Thursday after Bank of America (BofA) upgraded the stock from Neutral to Buy, citing improving medical cost trends. Goldman Sachs (GS) also rose nearly 5%, making them the top gainers in the Dow Jones Industrial Average.
Rating Change
- Stock: UnitedHealth (UNH)
- Analyst: BofA Securities
- Previous Rating: Neutral
- New Rating: Buy
- Price Target: Not disclosed
Analyst Rationale
BofA analysts believe that medical cost trends are improving, reducing pressure on UnitedHealth's profit margins. This improvement could boost the company's performance in upcoming quarters.
Context
The upgrade comes amid volatility in the health insurance sector due to rising healthcare costs. UnitedHealth's strong market performance reflects investor confidence in its cost management. Meanwhile, Goldman Sachs rose without a clear catalyst, likely benefiting from overall market momentum.
Conclusion
The BofA upgrade sends a positive signal for UnitedHealth, but investors should monitor medical cost trends in coming quarters. Goldman Sachs' rise may reflect broader optimism in the financial services sector.
Frequently Asked Questions
Found this useful? Share it